Wilson’s disease is a rare inherited metabolic disorder characterized by excessive accumulation of copper in the body. Because copper is essential only in small amounts, its buildup—particularly in the liver, brain, and eyes—can cause serious and potentially life-threatening complications. Accurate and timely diagnosis is crucial to prevent irreversible organ damage and improve long-term outcomes.

The disease is caused by mutations affecting copper transport and excretion. When copper is not properly eliminated through bile, it accumulates in tissues over time. Early symptoms are often subtle and nonspecific, including fatigue, abdominal discomfort, or mild behavioral changes. These vague signs frequently delay diagnosis, especially in children and young adults.

Diagnostic evaluation for Wilson’s disease involves a combination of clinical assessment, laboratory testing, and imaging. Blood tests measuring ceruloplasmin levels are commonly used, as this copper-binding protein is often reduced in affected individuals. Elevated liver enzymes may indicate hepatic involvement, prompting further investigation.

Urinary copper excretion testing plays a key role in confirming abnormal copper metabolism. Increased copper levels in a 24-hour urine sample strongly support the diagnosis. Ophthalmologic examination is also important, as copper deposition in the eyes may produce characteristic corneal rings visible under slit-lamp examination.

Genetic testing has become increasingly valuable, particularly for confirming diagnosis and screening family members. Identifying disease-causing mutations allows early detection in asymptomatic individuals, enabling preventive treatment before organ damage occurs.

Accurate diagnosis of Wilson’s disease requires a high index of suspicion and a systematic approach. When identified early, effective treatment can control copper levels and allow patients to lead healthy, productive lives.